Perspective Therapeutics
Price & Volume
Stats
See moreOpen | $2.60 |
Previous Close | $2.66 |
Day Range | $2.53-$2.63 |
52W Range | $1.95-$6.16 |
Market Cap | $303.6M |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $409,000 |
Revenue Growth (YoY) | -72.1% |
Gross Profit (12 Mos) | -$95.7M |
Diluted EPS | -$1.33 |
News
See moreYahoo Finance • 28 days ago
Perspective Therapeutics Announces Clinical Collaboration and Supply Agreement with Merck to Evaluate [212Pb]PSV359 in Combination with Keytruda® (Pembrolizumab) in FAP-α Positive Solid Tumors
Yahoo Finance • 3 months ago
Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs
Yahoo Finance • 3 months ago
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Oral Presentation at the ESMO Congress 2026
About
CEO | Mr. Johan M. Spoor |
CFO | Mr. Joel David Sendek |
Address | 2401 Elliott Avenue, Seattle, WA, United States, 98121 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 163 |